Home » FDA Tells Indevus of Drug Manufacturing Issues
FDA Tells Indevus of Drug Manufacturing Issues
Indevus Pharmaceuticals has received a nonapprovable letter from the U.S. Food and Drug Administration relating to its drug Valstar.
Mass High Tech
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May